Enovis Corp. (ENOV)
26.04
-0.20
(-0.74%)
USD |
NYSE |
Nov 20, 10:21
Enovis Free Cash Flow : 69.56M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 69.56M |
| June 30, 2026 | 63.66M |
| March 31, 2026 | 35.92M |
| December 31, 2025 | 19.92M |
| September 30, 2025 | 22.76M |
| June 30, 2025 | -3.952M |
| March 31, 2025 | -38.98M |
| December 31, 2024 | -67.21M |
| September 30, 2024 | -61.88M |
| June 30, 2024 | -60.26M |
| March 31, 2024 | -37.33M |
| December 31, 2023 | 12.76M |
| September 30, 2023 | -100.45M |
| June 30, 2023 | -105.89M |
| March 31, 2023 | -145.78M |
| December 31, 2022 | -161.31M |
| September 30, 2022 | -23.00M |
| June 30, 2022 | 46.64M |
| March 31, 2022 | 153.50M |
| December 31, 2021 | 251.86M |
| September 30, 2021 | 281.89M |
| June 30, 2021 | 262.47M |
| March 31, 2021 | 221.88M |
| December 31, 2020 | 187.15M |
| September 30, 2020 | 131.73M |
| Date | Value |
|---|---|
| June 30, 2020 | 101.86M |
| March 31, 2020 | 127.31M |
| December 31, 2019 | 5.546M |
| September 30, 2019 | 61.53M |
| June 30, 2019 | 94.34M |
| March 31, 2019 | 73.83M |
| December 31, 2018 | 156.72M |
| September 30, 2018 | 116.52M |
| June 30, 2018 | 87.06M |
| March 31, 2018 | 107.56M |
| December 31, 2017 | 150.00M |
| September 30, 2017 | 217.58M |
| June 30, 2017 | 224.61M |
| March 31, 2017 | 212.29M |
| December 31, 2016 | 183.72M |
| September 30, 2016 | 174.71M |
| June 30, 2016 | 216.30M |
| March 31, 2016 | 247.27M |
| December 31, 2015 | 233.94M |
| September 30, 2015 | 281.35M |
| June 30, 2015 | 355.72M |
| March 31, 2015 | 370.83M |
| December 31, 2014 | 304.42M |
| September 30, 2014 | 297.23M |
| June 30, 2014 | 237.90M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Edwards Lifesciences Corp. | 1.424B |
| Intuitive Surgical, Inc. | 3.598B |
| Kewaunee Scientific Corp. | 10.88M |
| STAAR Surgical Co. | 17.85M |
| Stryker Corp. | 4.573B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 71.49M |
| Cash from Investing (Quarterly) | -42.50M |
| Cash from Financing (Quarterly) | -28.50M |
| Free Cash Flow Per Share (Quarterly) | 0.5982 |
| Free Cash Flow to Equity (Quarterly) | 61.51M |
| Free Cash Flow to Firm (Quarterly) | -8.772M |
| Free Cash Flow Yield | 4.63% |